Session Details
[D1-A2]Quantitative Proteomics and its Application to Biomarker Research
Mon. Mar 3, 2025 12:50 PM - 2:30 PM JST
Mon. Mar 3, 2025 3:50 AM - 5:30 AM UTC
Mon. Mar 3, 2025 3:50 AM - 5:30 AM UTC
Medium Hall(2nd Floor)
Chairman:Eiichi Shimada(Ono Pharmaceuticals Co., Ltd.), Tomofumi Ohyama(Toray Research Center, Inc.)
[D1-A2-01]On Technical Assessment of Proteomics by Immuno-PCR Panel and Aptamer Panel
*Yoshiya Oda1 (1. Graduate School of Medicine, The University of Tokyo)
[D1-A2-02]Biomarker Discovery for ALS by Olink Proteomics
*Makoto Yamazaki1 (1. Mitsubishi Tanabe Pharma Corporation)
[D1-A2-03]Exploration of Biomarkers Utilizing Proteomic Platform at Chugai
*Kuniyasu Kato1, Toshiki Ueda2, Kazuhiro Morishita1, Yoshie Takashima1, Hiroko Noro3, Hanako Matsushima1, Kohji Nagano1, Ryoko Takubo2 (1. Biological Technology Dept., Chugai Pharmaceutical Co., Ltd., 2. Pharmaceutical Science Dept., Chugai Pharmaceutical Co., Ltd., 3. Experimental Technology Dept. 3, Chugai Research Institute For Medical Science, Inc.)